Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats

Citation
K. Matrougui et al., Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats, BR J PHARM, 130(3), 2000, pp. 521-526
Citations number
35
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
130
Issue
3
Year of publication
2000
Pages
521 - 526
Database
ISI
SICI code
0007-1188(200006)130:3<521:TAIAEM>2.0.ZU;2-M
Abstract
1 In resistance arteries pressure-induced (myogenic) tone (MT) and flow (sh ear stress)-induced dilation (FD) are potent determinant of vascular resist ance. We investigated the role of angiotensin II and endothelin-1 in FD and MT in resistance arteries and their potential change in hypertension. 2 Flow-diameter-pressure relationship was established in situ, under anaest hesia, in two daughter branches of a mesenteric resistance artery (180 mu M , n=7 per group) from spontaneously hypertensive (SHR) or normotensive (WKY ) rats. One artery was ligated distally, so that it was submitted to pressu re only, while the other was submitted to pressure and flow. Drugs were add ed to the preparation and external diameter, pressure and flow measured con tinuously. 3 External diameter (with flow) ranged from 150 +/- 3 to 191 +/- 7 mu M in WKY (n = 28) rats and from 168 +/- 6 to 186 +/- 6 mu M in SHR (n = 28). Flo w induced a dilation of the non-ligated arteries which was lower in SHR (13 +/- 5 - 31 +/- 4 mu M vs WKY: 5 +/- 5 - 44 +/- 4 mu M). In the ligated art ery, the diameter did not significantly change, due to MT. 4 In the vessels submitted to flow angiotensin converting enzyme inhibition (perindopril: 10 mu mol L-1) increased the diameter in SHR (+11 +/- 2 mu M ) significantly more than in WRY (+2 +/- 1 mu M). Angiotensin type 1 recept or (AT(1)R) blockade (losartan, 10 mu mol L-1) increased the diameter in th e vessels with flow in SHR only (+6 +/- 1 mu M). Angiotensin type 2 recepto r (AT(2)R) blockade (PD 123319, 1 mu mol L-1) decreased arterial diameter i n WKY only (9+/-2). Endothelin-1 type A receptor (ETAR) blockade (LU135252, 0.1 mu mol L-1) increased the diameter only in SHR in the artery submitted to flow (by 6 +/- 1 mu M). 5 Thus FD was counteracted by a flow-dependent AT(1) and ETA receptors-acti vation in SHR whereas in WKY FD AT(2)-dependent dilation is involved.